Lovastatin Nanoparticle Synthesis and Characterization for Better Drug Delivery

@article{Seenivasan2011LovastatinNS,
  title={Lovastatin Nanoparticle Synthesis and Characterization for Better Drug Delivery},
  author={A. Seenivasan and T. Panda and T. Th{\'e}odore},
  journal={The Open Biotechnology Journal},
  year={2011},
  volume={5},
  pages={28-32}
}
Nano drug delivery system is the latest technology employed in various medicinal applications. This technol- ogy can be adapted to the conventional drug administration due to its site-specific targeting phenomena. The oral lipo- philic drug administration has its drawbacks due to poor solubility and bioavailability. Lipid-based carrier systems are now widely popular due to improved efficiency, especially for lovastatin delivery. Lovastatin is an important drug which arrests the rate-limiting… Expand
Formulation and Evaluation of Chitosan Nanoparticles.
Nanoparticulate drug delivery systems (DDS) have attracted a lot of attention because of their size-dependent properties. Among the array of nanoparticles being currently investigated byExpand
Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect
TLDR
Zerumbone-loaded nanostructured lipid carriers (ZER-NLC) have potential as a sustained-release drug carrier system for the treatment of leukemia, according to physicochemical properties. Expand
Formulation and Nanotechnology-Based Approaches for Solubility and Bioavailability Enhancement of Zerumbone
TLDR
The importance of developing novel formulations of zerumbone to overcome its biopharmaceutical challenges thereby advance its potential in the treatment of various diseases is provided. Expand
Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs
TLDR
Drug dissolution under non-digesting intestinal conditions revealed a three- to sixfold increase in dissolution efficiencies when compared to the unformulated drug and a LOV-lipid suspension, and the SSL-S provided superior drug solubilization under simulated intestinal digesting condition. Expand
Nanoparticulate carrier system: a novel treatment approach for hyperlipidemia
TLDR
The importance and role of various nanoparticulate systems as carrier for antihyperlipidemic drugs in the treatment of hyperlipidemia and the development of efficient delivery methods and carriers are focused on. Expand
Cellular Localization and Production of Lovastatin from Monascus purpureus
Lovastatin is the first FDA-approved antihypercholesterolemic drug for the treatment of cardiovascular diseases with pleiotropic clinical applications. Monascus purpureus is one of the safest moldsExpand
Habit Modification of the Active Pharmaceutical Ingredient Lovastatin Through a Predictive Solvent Selection Approach.
TLDR
Crystals obtained from nitromethane solutions were found to have a very large reduction in aspect ratio to a prismatic morphology reflecting this solvent's propensity to interact with hydrophobic surfaces, critically with no polymorph change. Expand
Quantification of Lovastatin Produced by Monascus purpureus
Development of a novel method for the quantification of lovastatin is an interesting problem in the analytical field. In the literature, many reports use spectrophotometric method for theExpand

References

SHOWING 1-10 OF 15 REFERENCES
Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics.
TLDR
In vitro release kinetics demonstrated that lovastatin release could be reduced by up to 60% with lipid nanoparticles containing Myverol as the lipophilic emulsifier, which showed a decreasing order of NLCs>LEs>SLNs. Expand
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
TLDR
This review will primarily focus on the recent advances and updates on lipid-based nanoparticles for their projected applications in drug delivery, including a review of current activities in the field of liposomes, and challenging issues of targeting and triggering will be discussed in detail. Expand
Nanostructured Lipid Carriers : A Novel Generation of Solid Lipid Drug Carriers
I 1 Polymeric nanoparticles have been intensely investigated since their introduction by Speiser and co-workers in the mid-seventies. Despite their interesting properties, not many products made itExpand
Drug delivery strategies for poorly water-soluble drugs
TLDR
The emerging formulation designs for delivering of poorly water-soluble drugs, including the massive use of surface-active excipients for solubilisation, are addressed. Expand
Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.
TLDR
An overview of the cosmetic products currently on the market is given and the improvement of the benefit/risk ratio of the topical therapy is shown and the lipid nanoparticles are a "nanosafe" carrier. Expand
Solid lipid nanoparticles for parenteral drug delivery.
TLDR
The biological activity of parenterally applied SLN and biopharmaceutical aspects such as pharmacokinetic profiles as well as toxicity aspects are reviewed. Expand
Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles
TLDR
In vitro stability studies showed the slow release and stability of lovastatin SLN, and the relative bioavailabilities of lovaston hydroxy acid of SLN were increased by ∼173% and 324%, respectively, compared with the reference Lovastatin suspension. Expand
Solid lipid nanoparticles for targeted brain drug delivery.
The present review discusses the potential use of solid lipid nanoparticles for brain drug targeting purposes. The state of the art on surfactant-coated poly(alkylcyanoacrylate) nanoparticlesExpand
Nanostructured lipid carriers (NLC) in cosmetic dermal products.
TLDR
The article gives an overview of the cosmetic benefits of lipid nanoparticles, that means enhancement of chemical stability of actives, film formation, controlled occlusion, skin hydration, enhanced skin bioavailability and physical stability of the lipid nanoparticle as topical formulations. Expand
Potential of solid lipid nanoparticles in brain targeting.
TLDR
The barriers to CNS drug delivery, strategies to bypass the blood-brain barrier and characterization methods of SLNs and their usefulness are discussed. Expand
...
1
2
...